An Improved Phenotype-Driven Tool for Rare Mendelian Variant Prioritization: Benchmarking Exomiser on Real Patient Whole-Exome Data.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
23 04 2020
Historique:
received: 11 03 2020
revised: 08 04 2020
accepted: 16 04 2020
entrez: 29 4 2020
pubmed: 29 4 2020
medline: 27 3 2021
Statut: epublish

Résumé

Next-generation sequencing has revolutionized rare disease diagnostics, but many patients remain without a molecular diagnosis, particularly because many candidate variants usually survive despite strict filtering. Exomiser was launched in 2014 as a Java tool that performs an integrative analysis of patients' sequencing data and their phenotypes encoded with Human Phenotype Ontology (HPO) terms. It prioritizes variants by leveraging information on variant frequency, predicted pathogenicity, and gene-phenotype associations derived from human diseases, model organisms, and protein-protein interactions. Early published releases of Exomiser were able to prioritize disease-causative variants as top candidates in up to 97% of simulated whole-exomes. The size of the tested real patient datasets published so far are very limited. Here, we present the latest Exomiser version 12.0.1 with many new features. We assessed the performance using a set of 134 whole-exomes from patients with a range of rare retinal diseases and known molecular diagnosis. Using default settings, Exomiser ranked the correct diagnosed variants as the top candidate in 74% of the dataset and top 5 in 94%; not using the patients' HPO profiles (i.e., variant-only analysis) decreased the performance to 3% and 27%, respectively. In conclusion, Exomiser is an effective support tool for rare Mendelian phenotype-driven variant prioritization.

Identifiants

pubmed: 32340307
pii: genes11040460
doi: 10.3390/genes11040460
pmc: PMC7230372
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Department of Health
Pays : United Kingdom

Références

Nat Protoc. 2015 Oct;10(10):1556-66
pubmed: 26379229
Genome Res. 2005 Aug;15(8):1034-50
pubmed: 16024819
Nat Methods. 2015 Sep;12(9):841-3
pubmed: 26192085
Nat Genet. 2018 Aug;50(8):1161-1170
pubmed: 30038395
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Nucleic Acids Res. 2019 Jul 2;47(W1):W114-W120
pubmed: 31106342
Genet Med. 2017 Oct;19(10):1151-1158
pubmed: 28518168
Am J Hum Genet. 2018 Jul 5;103(1):58-73
pubmed: 29961570
BMC Genomics. 2013;14 Suppl 3:S3
pubmed: 23819870
Am J Hum Genet. 2016 Sep 1;99(3):595-606
pubmed: 27569544
Am J Hum Genet. 2008 Nov;83(5):610-5
pubmed: 18950739
Genome Biol. 2017 Jan 16;18(1):6
pubmed: 28093075
Hum Mutat. 2013 Aug;34(8):1057-65
pubmed: 23636887
Nat Genet. 2016 Feb;48(2):214-20
pubmed: 26727659
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
Am J Med Genet A. 2016 Dec;170(12):3106-3114
pubmed: 27513830
Hum Mutat. 2018 Nov;39(11):1623-1630
pubmed: 30311387
Sci Transl Med. 2014 Sep 3;6(252):252ra123
pubmed: 25186178
J Med Genet. 2014 Jul;51(7):444-8
pubmed: 24737827
Nucleic Acids Res. 2014 Jan;42(Database issue):D966-74
pubmed: 24217912
Nat Rev Genet. 2017 Oct;18(10):599-612
pubmed: 28804138
Nucleic Acids Res. 2013 Jan;41(Database issue):D854-60
pubmed: 23074187
Hum Mutat. 2013 Apr;34(4):566-71
pubmed: 23378291
Hum Mutat. 2013 Jan;34(1):57-65
pubmed: 23033316
PLoS Comput Biol. 2010 Dec 02;6(12):e1001025
pubmed: 21152010
Bioinformatics. 2017 Aug 01;33(15):2421-2423
pubmed: 28334266
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Genome Res. 2009 Sep;19(9):1553-61
pubmed: 19602639
Genome Res. 2014 Feb;24(2):340-8
pubmed: 24162188
Nat Rev Genet. 2011 Sep 27;12(11):745-55
pubmed: 21946919
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Clin Genet. 2010 Mar;77(3):201-13
pubmed: 20002459
Nat Methods. 2014 Sep;11(9):935-7
pubmed: 25086502
Nat Methods. 2010 Aug;7(8):575-6
pubmed: 20676075
Hum Mutat. 2014 May;35(5):548-55
pubmed: 24677618
Bioinformatics. 2019 Oct 1;35(19):3559-3566
pubmed: 30843052
Ophthalmology. 2020 Oct;127(10):1384-1394
pubmed: 32423767
Bioinformatics. 2014 Sep 1;30(17):2503-5
pubmed: 24812344
Nat Rev Genet. 2018 May;19(5):325
pubmed: 29456250
Eur J Hum Genet. 2017 Feb;25(2):200-207
pubmed: 27876815
Nucleic Acids Res. 2017 Jan 4;45(D1):D865-D876
pubmed: 27899602
Bioinformatics. 2015 Dec 15;31(24):4029-31
pubmed: 26315906
Bioinformatics. 2017 Apr 1;33(7):1104-1106
pubmed: 28062448
Hum Mol Genet. 2015 Apr 15;24(8):2125-37
pubmed: 25552646
Hum Mol Genet. 2018 Feb 15;27(4):691-705
pubmed: 29300972
Nucleic Acids Res. 2019 Jan 8;47(D1):D1018-D1027
pubmed: 30476213
Hum Mutat. 2017 Apr;38(4):373-377
pubmed: 28054444
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W88-93
pubmed: 24803668
Genet Med. 2019 Feb;21(2):464-470
pubmed: 29997393
BMC Bioinformatics. 2019 Feb 6;20(1):65
pubmed: 30727941
PLoS One. 2012;7(10):e46688
pubmed: 23056405
Genet Med. 2019 Sep;21(9):2126-2134
pubmed: 30675030
Sci Rep. 2015 May 27;5:10576
pubmed: 26015273
Bioinformatics. 2015 Dec 1;31(23):3822-9
pubmed: 26272982
Bioinformatics. 2015 Mar 1;31(5):761-3
pubmed: 25338716
Database (Oxford). 2013 May 09;2013:bat025
pubmed: 23660285
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4552-4557
pubmed: 30208423
Am J Hum Genet. 2016 Oct 6;99(4):877-885
pubmed: 27666373
Genome Res. 2001 May;11(5):863-74
pubmed: 11337480
Nucleic Acids Res. 2011 Sep 1;39(17):e118
pubmed: 21727090
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Am J Hum Genet. 2014 Apr 3;94(4):599-610
pubmed: 24702956
Genome Res. 2002 Mar;12(3):436-46
pubmed: 11875032
Am J Hum Genet. 2017 Jan 5;100(1):75-90
pubmed: 28041643
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Bioinformatics. 2009 Jun 15;25(12):i54-62
pubmed: 19478016
BMJ. 2018 Apr 24;361:k1687
pubmed: 29691228
Blood Adv. 2018 Nov 13;2(21):2959-2963
pubmed: 30404775
Nucleic Acids Res. 2019 Jul 2;47(W1):W566-W570
pubmed: 31106327
Hum Mol Genet. 2016 Aug 15;25(16):3407-3415
pubmed: 27329761
Bioinformatics. 2015 May 15;31(10):1536-43
pubmed: 25583119
Nucleic Acids Res. 2018 Jan 4;46(D1):D836-D842
pubmed: 29092072
Hum Mutat. 2012 May;33(5):803-8
pubmed: 22422702
Nat Methods. 2013 Nov;10(11):1083-4
pubmed: 24076761
BMC Med Genomics. 2014 May 12;7:22
pubmed: 24884844
BMC Bioinformatics. 2018 Jan 27;19(1):25
pubmed: 29374474
Eur J Hum Genet. 2019 Apr;27(4):612-620
pubmed: 30626929
Nat Protoc. 2015 Dec;10(12):2004-15
pubmed: 26562621
Orphanet J Rare Dis. 2019 Jan 9;14(1):8
pubmed: 30626441
Nucleic Acids Res. 2018 Sep 6;46(15):7793-7804
pubmed: 30060008
Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2):
pubmed: 30755392
Clin Genet. 2020 Feb;97(2):235-245
pubmed: 31506931
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Hum Mol Genet. 2015 Feb 15;24(4):1119-26
pubmed: 25305078
Nucleic Acids Res. 2019 Jan 8;47(D1):D1038-D1043
pubmed: 30445645
Genet Med. 2016 Jun;18(6):608-17
pubmed: 26562225
Genome Med. 2016 Feb 02;8(1):13
pubmed: 26838676
Clin Genet. 2018 Mar;93(3):508-519
pubmed: 29206278
BMC Bioinformatics. 2017 Apr 28;18(1):225
pubmed: 28454514
Nat Rev Genet. 2013 Oct;14(10):681-91
pubmed: 23999272
Nat Genet. 2016 Dec;48(12):1581-1586
pubmed: 27776117
Nat Genet. 2015 Mar;47(3):276-83
pubmed: 25599402

Auteurs

Valentina Cipriani (V)

William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK.
UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
UCL Genetics Institute, University College London, London WC1E 6AA, UK.

Nikolas Pontikos (N)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.

Gavin Arno (G)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
North East Thames Regional Genetics Laboratory, Great Ormond Street Hospital NHS Trust, London WC1N 3BH, UK.

Panagiotis I Sergouniotis (PI)

Manchester Royal Eye Hospital & University of Manchester, Manchester M13 9WL, UK.

Eva Lenassi (E)

Manchester Royal Eye Hospital & University of Manchester, Manchester M13 9WL, UK.

Penpitcha Thawong (P)

Department of Medical Sciences, Medical Genetics Section, National Institute of Health, Ministry of Public Health, Nonthaburi 11000, Thailand.

Daniel Danis (D)

The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.

Michel Michaelides (M)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.

Andrew R Webster (AR)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.

Anthony T Moore (AT)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Ophthalmology Department, UCSF School of Medicine, San Francisco, CA 94143-0644, USA.

Peter N Robinson (PN)

The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.

Julius O B Jacobsen (JOB)

William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK.

Damian Smedley (D)

William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH